Photoaffinity Labeling of P-Glycoprotein in Multidrug-Resistant Cells

References

• Fedan JS, Hogaboom GK, O'Donneli JP. Photoaffinity labels as pharmacological tools. Biochem Pharmacol 1984; 33: 1167–1180
   PubMed Web of Science ®Google Scholar
• Cavalla D, Neff NH. Chemical mechanisms for photoaffinity labeling of rcceptors. Biochem Pharmacol 1985; 34: 2821–2826
   PubMed Web of Science ®Google Scholar
• Bayley H, Knowles JR. Photoaffinity labeling. Methods Enzymol 1977; 46: 69–115
   PubMedGoogle Scholar
• Safa AR, Glover CJ, Meyers MB, et al. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug resistance. J Biol Chem 1986; 261: 6137–6140
   PubMed Web of Science ®Google Scholar
• Safa AR, Glover CG, Sewell JL, et al. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem 1987; 262: 7884–7888
   PubMed Web of Science ®Google Scholar
• Safa AR. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapaniil. Proc Natl Acad Sci (USA) 1988; 85: 7187–7191
   PubMed Web of Science ®Google Scholar
• Safa AR, Mehta ND, Agresti M. Photoaffinity labeling of P-glycoprotein in mukidrug resistant cells with photoactive analogs of colchicine. Biochem Biophys Res Commun 1989; 162: 1402–1408
   PubMed Web of Science ®Google Scholar
• Biedler JL, Meyers MB, Spengler BA. Cellular concomitants of multidrug resistance. Mechansims of Drug Resistance in Neoplastic Cells. Bristol-Meyers Cancer Symposia, PV. Wooley, III. KD Tew. Academic Press, New York 1988; Vol. 9.: 41–68
   Google Scholar
• Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989; 58: 137–171
   PubMed Web of Science ®Google Scholar
• Gros P, Croop J, Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicate strong homology to bacterial transport proteins. Cell 1986; 47: 371–380
   PubMed Web of Science ®Google Scholar
• Chen C-J, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–389
   PubMed Web of Science ®Google Scholar
• Gerlach JH, Endicot JA, Juranka PF, et al. Homology between P-glycoprotein and bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature (London) 1986; 324: 485–489
   PubMed Web of Science ®Google Scholar
• Azzaria M, Schurr E, Gros P. Direct mutations introduced in the predicted nucleotide-binding sites of the mdr I gene abolish its ability to confer multidrug resistance. Mol Cell Biol 1989; 9: 5289–5297
   PubMed Web of Science ®Google Scholar
• Gros P, Ben Neriah Y, Croop JM, et al. Isolation and expression of a complementary DNA that confers mukidrug resistance. Nature (London) 1986; 323: 728–731
   PubMed Web of Science ®Google Scholar
• Tamai I, Safa AR. Competitive interaction of cyclosporins with the vinca alkaloid-binding site of P-glycoprotein in multidrug resistant cells. J Biol Chem 1990; 265: 16509–16513
   PubMed Web of Science ®Google Scholar
• Horio M, Gottesman MM, Pastan I. ATP-dependent transport of vinblastine from human multidrug resistant cells. Proc Natl Acad Sci (USA) 1990; 85: 3580–3584
   Web of Science ®Google Scholar
• Naito N, Tsuruo T. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of mukidrug-resistant K562 cells without calcium ion involvement. Cancer Res 1989; 49: 1452–1455
   PubMed Web of Science ®Google Scholar
• Safa AR. P-glycoprotein as a target for chemosensitizing agents. Anticancer Drugs, H Tapiero, J Robert, TJ Lampidis. Colloque INSERM/John Libbey Eurotext Ltd. 1989; Vol. 191: 277–287
   Google Scholar
• Gottesman MM., Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem 1988; 263: 12163–12166
   PubMed Web of Science ®Google Scholar
• Juranka PF, Zastawny RL, Ling V. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J 1989; 3: 2583–2592
   PubMed Web of Science ®Google Scholar
• Hamada H, Hagiwara KI, Nakajima T, et al. Phosphorylation of the Mr. 170.000 to 180.000 glycoprotein specific to multidrug-resistant tumor cells Effects of verapamil, tritluoperazinc and phorbol esters. Cancer Res 1987; 47: 2860–2865
   PubMed Web of Science ®Google Scholar
• Chambers TC, McAvoy EM, Jacobs JW, et al. Protein kinase C phosphorylates P-glycoprotein in niultidrug resiatant human KB carcinoma cells. J Biol Chem 1990; 265: 7679–7686
   PubMed Web of Science ®Google Scholar
• Mellado M, Horwitz SB. Phosphorylation of the inultidrup rcsistance associated glycoprotein. Biochemistry 1987; 26: 6900–6904
   PubMed Web of Science ®Google Scholar
• Staats J, Marquardt D, Center MS. Characterization of a incinbrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J Biol Chem 1990; 265: 4084–4090
   PubMed Web of Science ®Google Scholar
• Yu G, Aquino A, Fairchild CR, et al. Adrianiycin resistance in MCF-7 cells expressing P-glycoprotein followins transfection with protein kinase Cα. Proc Am Assoc Cancer Res 1990; 31: 366
   Google Scholar
• Safa AR, Felsted RL. Specific vinca alkaloid-binding polypeptides identified in calf brain by photoaffinity labeling. J Biol Chem 1987; 262: 1261–1267
   PubMed Web of Science ®Google Scholar
• Safa AR, Hainel E, Felsted RL. Photoaffinity labeling of tubulin subunits with a photoactive analogue of vinblastine. Biochemistry 1987; 26: 97–102
   PubMed Web of Science ®Google Scholar
• Safa AR, Glover CJ, Felbted RL. Identification of vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine. Cancer Res 1987; 47: 5149–5154
   PubMed Web of Science ®Google Scholar
• Cornwell MM, Safa AR, Felsted RL, et al. Membrane vesicles from niultidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci (USA) 1986; 83: 3847–3850
   PubMed Web of Science ®Google Scholar
• Busche R, Burkhard T, Riordan JR, et al. Preparation and utility of a radio analogue of daunomycin in the study of mukidrug resistance. Mol Pharm 1989; 35: 414–421
   Web of Science ®Google Scholar
• Tsuruo T, Lida H, Tsukagoshi S. Overcoming vincristine reaistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981; 41: 1967–1972
   PubMed Web of Science ®Google Scholar
• Kessel D, Wilberding C. Anthracycline resistance in P388 murine leukemia and its circumventioni by calcium antagonists. Cancer Res 1985; 45: 1687–1691
   PubMed Web of Science ®Google Scholar
• Qian X-D, Beck WT. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Cancer Res 1990; 50: 1132–1137
   PubMed Web of Science ®Google Scholar
• Yang C-PH, DePinho SG, Greenberger LM, et al. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and the endometrium of gravid uterus. J Biol Chem 1989; 264: 782–788
   PubMed Web of Science ®Google Scholar
• Ichikawa M, Yoshimurd A, Sumizawa K, et al. Interaction of organic chemicals with P-glycoprotein in the adrenal gland. kidney, and a niultidrug-resistant KB cells. J Biol Chem 1991; 266: 903–908
   PubMed Web of Science ®Google Scholar
• Twentyinan PR. Modification of cytotoxic drug rcaistance by nonimmuno-suppressive cyclosporins. Br J Cancer 1988; 57: 254–258
   PubMed Web of Science ®Google Scholar
• Foxwell BMJ, Mackie A, Ling V, et al. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporin binding protein. Mol Pharamcol 1989; 36: 543–546
   PubMed Web of Science ®Google Scholar
• Goldberg HV, Ling V, Wong P, et al. Reduced cyclosporin accumulation in multidrug resistant cells. Biochem Biophys Res Commun 1988; 152: 552–558
   PubMed Web of Science ®Google Scholar
• Akiyama S-I, Yoshimura A, Kikuchi H, et al. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells. Mol Pharmacol 1989; 36: 730–735
   PubMed Web of Science ®Google Scholar
• Naito M, Yusa K, Tsuruo T. Steroid hormones inhibit binding of vinca alkaloid to multidrug resistance related P-glycoprotein. Biochem Biophys Res Commun 1989; 158: 1066–1071
   PubMed Web of Science ®Google Scholar
• Qian X-D, Beck WT. Progesterone photoaffinity labels P-glycoprotein in multidrug resistant human leukemic lymphoblasts. J Biol Chem 1990; 265: 18753–18756
   PubMed Web of Science ®Google Scholar
• Yang C-PH, Cohen D, Greenberger LM, et al. Differential transport properties of two mdr gene products are distinguished by progesterone. J Biol Chem 1990; 265: 10282–10288
   PubMed Web of Science ®Google Scholar
• Zamora JM, Pearce HL, Bect WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 1988; 33: 454–462
   PubMed Web of Science ®Google Scholar
• Pearce HL, Safa AR, Bach NJ, et al. Essential features of the P-glycoprotein phamiacophore as defined by a series of reserpine analogs that modulate multidrug resistance. Proc Natl Acad Sci (USA) 1989; 86: 5128–5132
   PubMed Web of Science ®Google Scholar
• Beck WT, Cirtain MC, Glover CJ, et al. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analogue of vinblastine. Biochem Biophys Res Commun 1988; 153: 959–966
   PubMed Web of Science ®Google Scholar
• Kiue A, Sano T, Suzuki K, et al. Activities of newly synthesized dihydropyridines in overcoming of vincristine resistance. calcium antagonism. and inhibition of photoaffinity labeling of P-glycoprotein in rodents. Cancer Res 1990; 50: 310–317
   PubMed Web of Science ®Google Scholar
• Safa AR, Agresti M, Tamai I, et al. The α1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug resistant cells. Biochem Biophys Res Commun 1990; 166: 259–266
   PubMed Web of Science ®Google Scholar
• Greenberger LM, Yang C-PH, Gindin E, et al. Photoaffinity probes for the α1-adrenergic receptor and the calcium channel bind to a common domain in P-plycoprotein. J Biol Chein 1990; 265: 4394–4401
   PubMed Web of Science ®Google Scholar
• Akiyama S-I, Cornwell MM, Kuwano K, et al. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol Pharmacol 1988; 33: 144–147
   PubMed Web of Science ®Google Scholar
• Cornwell MM, Pastan I, Gottesmann MM. Certain calcium channel blockers bind specifically to multidrug resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 1987; 262: 2166–2170
   PubMed Web of Science ®Google Scholar
• Friche E, Jensen PB, Shested M, et al. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun 1990; 2: 297–303
   PubMed Web of Science ®Google Scholar
• Tamai I, Safa AR. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J Biol Chem 1991; 266: 16796–16800
   PubMed Web of Science ®Google Scholar
• Bruggermann EP, Germann UA, Gottesman MM, et al. Two different regions of phosphoglycoprotein are photoaffinity labclcd by azidopine. J Biol Chem 1989; 264: 15483–15488
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Kuwazuru Y, Sumizawa T, et al. Cytoplasmic orientation and two-domain structure of the multidrug transporter. P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 1989; 264: 16282–16291
   PubMed Web of Science ®Google Scholar
• Choi K, Chen C-J, Kriegler M, et al. An altered pattern of cross-resistance in multidrug-resistant cells results from spontaneous mutations in the mdr I (P-glycoprotein) gene. Cell 1988; 53: 519–529
   PubMed Web of Science ®Google Scholar
• Safa AR, Kaplan Stern R, Choi K, et al. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci (USA) 1990; 87: 7225–7229
   PubMed Web of Science ®Google Scholar
• Brandt-Rauf PW, Lee G, Carty RP, et al. Conformational effects of amino acid substitution in the P-glycoprotein of the mdr I gene. J. Protein Chem 1989; 8: 563–573
   Google Scholar
• Goldstein LJ, Galaski H, Fojo A, et al. Expression of multidrup resistance gene in human tumors. J Natl Cancer lnst 1989; 81: 116–124
   PubMed Web of Science ®Google Scholar
• Thiebaut T, Tsuruo Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci (USA) 1987; 84: 7735–7738
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C., O'Brian JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci (USA) 1989; 86: 695–698
   PubMed Web of Science ®Google Scholar
• Chan HSL, Thorner PS, Haddad G, et al. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689–704
   PubMed Web of Science ®Google Scholar
• Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR l (multidrug resistance) gene expression in human tumors by polymerase chain rcaction. Proc Natl Acad Sci (USA) 1990; 87: 7160–7164
   PubMed Web of Science ®Google Scholar
• Salmon SE, Grogan TM, Miller T, et al. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma. and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 1989; 81: 696–701
   PubMed Web of Science ®Google Scholar
• Shier WT. Implications of drug pumps (P-glycoprotein) for toxin research. J Toxicol-Toxin Rev 1987; 6: 73–97
   Web of Science ®Google Scholar
• Ames B, Profet M, Gold IS. Dietary pesticides (99.9% all natural). Proc Natl Acad Sci (USA) 1990; 87: 7777–7781
   PubMed Web of Science ®Google Scholar
• Gosland MP, Brophy NA, Duran GE, et al. Bilirubin: a physiological substrate for the multidrug transporter. Proc Am Assoc Cancer Res 1991; 32: 426
   Google Scholar
• Samuels B, Ratain A, Safa AR, et al. Phase I trial of vinblastine (VBL) with continuous infusion cyclosporin A (CSA) as a modulator of multidrug resistance (MDR). Proc Am Assoc Clin Oncol 1990; 9: 74
   Google Scholar
• Samuels B, Murray J, Sherman J, et al. Combination multidrug resistance modulation: synergism and additivity. Proc Am Assoc Cancer Res 1991; 32: 376
   Google Scholar